Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome-Reference-Cited by-同舟云学术

Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome

Published:2011-06-16 Issue:4 Volume:34 Page:432-442
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Clavé P.,Acalovschi M.,Triantafillidis J. K.,Uspensky Y. P.,Kalayci C.,Shee V.,Tack J.,

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2011.04730.x/fullpdf

Reference24 articles.

1. Functional bowel disorders;Longstreth;Gastroenterology,2006

2. Consensus report: clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome;Camilleri;Aliment Pharmacol Ther,2002

3. Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar;Dorn;J Clin Gastroenterol,2009

4. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects;Hungin;Aliment Pharmacol Ther,2003

5. AGA technical review on irritable bowel syndrome;Drossman;Gastroenterology,2002

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Technologies and Prospects in the Treatment of Visceral Pain;Visceral Pain;2024

2. Abdominal pain syndrome in patients with irritable bowel syndrome: features of selection of therapy;Meditsinskiy sovet = Medical Council;2023-11-02

3. Randomized clinical trial: A phase 2b controlled study of the efficacy and safety of trazpiroben (TAK‐906) for idiopathic or diabetic gastroparesis;Neurogastroenterology & Motility;2023-08-03

4. Update on treatment of abdominal pain in irritable bowel syndrome: A narrative review;Pharmacology & Therapeutics;2023-05

5. Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead;Gut Microbes;2023-04-03